DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,645,907 | +4.2% | 87,247 | +0.8% | 1.60% | +7.0% |
| Q2 2023 | $20,764,710 | -2.5% | 86,520 | +2.4% | 1.50% | -4.2% |
| Q1 2023 | $21,303,313 | -3.6% | 84,524 | +1.5% | 1.56% | -10.0% |
| Q4 2022 | $22,106,690 | -3.2% | 83,289 | -5.8% | 1.74% | -9.1% |
| Q3 2022 | $22,832,000 | -23.4% | 88,395 | -24.8% | 1.91% | -16.3% |
| Q2 2022 | $29,809,000 | +68.5% | 117,582 | +94.9% | 2.28% | +74.7% |
| Q1 2022 | $17,695,000 | -10.4% | 60,326 | +0.5% | 1.31% | -9.4% |
| Q4 2021 | $19,754,000 | +8.6% | 60,041 | +0.5% | 1.44% | -1.4% |
| Q3 2021 | $18,186,000 | +14.5% | 59,737 | +0.9% | 1.46% | +11.7% |
| Q2 2021 | $15,883,000 | +22.3% | 59,184 | +2.5% | 1.31% | +10.7% |
| Q1 2021 | $12,991,000 | -54.5% | 57,718 | -55.1% | 1.18% | -66.2% |
| Q4 2020 | $28,568,000 | +136.5% | 128,605 | +129.2% | 3.49% | +43.6% |
| Q3 2020 | $12,082,000 | -2.2% | 56,111 | -19.7% | 2.43% | -8.1% |
| Q2 2020 | $12,358,000 | +18.9% | 69,887 | -6.9% | 2.64% | -2.3% |
| Q1 2020 | $10,393,000 | -10.8% | 75,092 | -1.1% | 2.71% | +14.7% |
| Q4 2019 | $11,650,000 | -9.3% | 75,909 | -14.7% | 2.36% | -8.6% |
| Q3 2019 | $12,851,000 | -1.0% | 88,976 | -2.0% | 2.58% | +3.9% |
| Q2 2019 | $12,980,000 | +3.1% | 90,821 | -4.8% | 2.48% | +1.0% |
| Q1 2019 | $12,591,000 | -32.2% | 95,371 | -47.1% | 2.46% | -11.5% |
| Q4 2018 | $18,583,000 | -3.1% | 180,211 | +2.1% | 2.78% | +13.4% |
| Q3 2018 | $19,184,000 | +8.2% | 176,553 | -1.8% | 2.45% | +1.4% |
| Q2 2018 | $17,737,000 | -1.4% | 179,744 | -2.2% | 2.42% | -2.5% |
| Q1 2018 | $17,992,000 | +6.2% | 183,762 | +0.7% | 2.48% | +10.4% |
| Q4 2017 | $16,944,000 | +7.3% | 182,552 | -0.8% | 2.24% | +3.8% |
| Q3 2017 | $15,788,000 | +1.5% | 184,049 | -0.2% | 2.16% | -2.3% |
| Q2 2017 | $15,562,000 | -0.6% | 184,408 | +0.8% | 2.21% | -1.2% |
| Q1 2017 | $15,650,000 | +9.9% | 182,976 | +0.0% | 2.24% | +7.5% |
| Q4 2016 | $14,241,000 | -0.3% | 182,950 | +0.4% | 2.08% | -2.5% |
| Q3 2016 | $14,278,000 | -22.6% | 182,142 | -0.3% | 2.14% | -22.3% |
| Q2 2016 | $18,456,000 | +5.1% | 182,737 | -1.3% | 2.75% | +6.8% |
| Q1 2016 | $17,558,000 | +1.4% | 185,092 | -0.8% | 2.58% | +2.2% |
| Q4 2015 | $17,324,000 | +7.6% | 186,517 | -1.3% | 2.52% | +6.5% |
| Q3 2015 | $16,102,000 | -0.4% | 188,969 | +0.1% | 2.37% | +9.4% |
| Q2 2015 | $16,161,000 | -1.5% | 188,821 | -2.3% | 2.16% | +0.3% |
| Q1 2015 | $16,412,000 | -13.5% | 193,314 | -12.7% | 2.16% | -6.0% |
| Q4 2014 | $18,969,000 | +2.6% | 221,319 | -9.1% | 2.29% | -4.0% |
| Q3 2014 | $18,493,000 | -6.5% | 243,396 | -3.1% | 2.39% | -6.1% |
| Q2 2014 | $19,769,000 | +3.6% | 251,102 | -1.3% | 2.54% | +1.8% |
| Q1 2014 | $19,079,000 | -3.7% | 254,386 | -0.9% | 2.50% | -3.3% |
| Q4 2013 | $19,810,000 | +11.9% | 256,607 | +0.4% | 2.58% | +4.6% |
| Q3 2013 | $17,709,000 | +9.6% | 255,468 | +0.0% | 2.47% | +6.8% |
| Q2 2013 | $16,165,000 | – | 255,368 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |